Impaired receptor binding and activation associated with a human prostacyclin receptor polymorphism.
about
High throughput mutagenesis for identification of residues regulating human prostacyclin (hIP) receptor expression and functionPharmacologic treatments for pulmonary hypertension: exploring pharmacogenomicsComprehensive biochemical analysis of rare prostacyclin receptor variants: study of association of signaling with coronary artery obstruction.RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists.Aging-shifted prostaglandin profile in endothelium as a factor in cardiovascular disordersArginine (CGC) codon targeting in the human prostacyclin receptor gene (PTGIR) and G-protein coupled receptors (GPCR).New insights into human prostacyclin receptor structure and function through natural and synthetic mutations of transmembrane charged residues.Regulation of the human prostacyclin receptor gene by the cholesterol-responsive SREBP1.Genetic variation in G-protein-coupled receptors--consequences for G-protein-coupled receptors as drug targets.Future perspectives for the treatment of pulmonary arterial hypertension.An eicosanoid-centric view of atherothrombotic risk factorsNovel signaling pathways promote a paracrine wave of prostacyclin-induced vascular smooth muscle differentiation.Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition.A Report of a Novel Mutation in Human Prostacyclin Receptor Gene in Patients Affected with Migraine.The unique ligand-binding pocket for the human prostacyclin receptor. Site-directed mutagenesis and molecular modeling.Endogenous PGI2 signaling through IP inhibits neutrophilic lung inflammation in LPS-induced acute lung injury mice model.
P2860
Q28539230-57742F0B-78B7-4EA4-8950-E420323296ACQ34344390-24E4C4A1-678A-4546-BB44-BA7EB4D10623Q34606153-AE31F2C6-3D2E-4067-A405-3C63228AE9E5Q35545236-33C8E844-9857-4D15-814B-5448D8D8E21BQ35829890-035C5D8D-EDA2-41B6-853C-BC231E36190CQ36056917-E321CEDB-9CEC-4EF1-856E-E314B12DB05DQ36104901-A9F2A8E4-41D9-481E-AAEF-6A081F23DBCFQ36302755-A21ADA41-3D24-403B-8AD4-4D136B380188Q36318560-3CAA6413-88C9-4EC5-B2F6-DC93A6556A9EQ36943648-3FAA71CC-6BB7-4C3F-8CA2-196F7C12F668Q36952174-8B227FD3-5ECC-4E14-AA14-48FF3E38C109Q37214880-F2CD1941-9A8B-4A44-81D9-D5D6AAC287C0Q37476384-2F0B4957-8215-4905-9BC4-90F959DE525BQ43872293-EB94CD18-CDE0-4B87-AD1A-511764038B0BQ44226149-EF31F101-5965-4398-B7E8-458363312F6DQ52719088-B6671BA1-287D-4920-8FCB-CA7625B08B9D
P2860
Impaired receptor binding and activation associated with a human prostacyclin receptor polymorphism.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Impaired receptor binding and ...... acyclin receptor polymorphism.
@en
Impaired receptor binding and ...... acyclin receptor polymorphism.
@nl
type
label
Impaired receptor binding and ...... acyclin receptor polymorphism.
@en
Impaired receptor binding and ...... acyclin receptor polymorphism.
@nl
prefLabel
Impaired receptor binding and ...... acyclin receptor polymorphism.
@en
Impaired receptor binding and ...... acyclin receptor polymorphism.
@nl
P2093
P2860
P356
P1476
Impaired receptor binding and ...... acyclin receptor polymorphism.
@en
P2093
Aleksandar Stojanovic
Jeremiah Stitham
P2860
P304
15439-15444
P356
10.1074/JBC.M201187200
P407
P577
2002-02-19T00:00:00Z